0

Dibenz[c,h]acridine

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP224533
CAS224-53-3
Structure
MDL NumberMFCD00215937
Molecular Weight279.33
InChI KeyBTVBCAKHMZHLFR-UHFFFAOYSA-N
REAXYS Number209259
Descriptioncertified Reference Material
Formneat
Gradecertified Reference Material
Size10MG
Storage Conditions2-8°C
1

Bacterial and Mammalian Cell Mutagenicity of Four Optically Active Bay-Region 3,4-diol-1,2-epoxides and Other Derivatives of the Nitrogen Heterocycle Dibenz[c,h]acridine

A W Wood, R L Chang, W Levin, S Kumar, N Shirai, D M Jerina, R E Lehr, A H Conney

Cancer Res. 1986 Jun;46(6):2760-6.

PMID: 3516386

1

Dibenz[a,h]acridine

IARC Monogr Eval Carcinog Risk Chem Hum. 1983 Dec;32:277-81.

PMID: 6586658

1

Metabolism of Dibenz[a,h]acridine by Rat Liver Microsomes

A R Steward, S Kumar, H C Sikka

Carcinogenesis. 1987 Aug;8(8):1043-50.

PMID: 3608088

1

Stereoselective Metabolism of Dibenz[a,h]acridine to Bay-Region Diol Epoxides by Rat Liver Microsomes

S Kumar, S K Singh, P L Kole, S Elmarakby, H C Sikka

Carcinogenesis. 1995 Mar;16(3):525-30.

PMID: 7697809

1

Tumorigenicity of Four Optically Active Bay-Region 3,4-diol 1, 2-epoxides and Other Derivatives of the Nitrogen Heterocycle Dibenz[c,h]acridine on Mouse Skin and in Newborn Mice

R L Chang, A W Wood, S Kumar, R E Lehr, N Shirai, D M Jerina, A H Conney

Carcinogenesis. 2000 Nov;21(11):1997-2003.

PMID: 11062160

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode